You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 12, December 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Laryngology/ Speech/ Language Pathology
 •Neoplasms of Head & Neck
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Significance of PCNA Expression in Laryngeal Cancer

Sarp Saraç, MD; Ayse Ayhan, MD; A. Sefik Hosal, MD; Sefa Kaya, MD

Arch Otolaryngol Head Neck Surg. 1998;124:1321-1324.

Objective  To assess the prognostic value of proliferating cell nuclear antigen (PCNA) in laryngeal carcinoma and its relation with other known prognostic clinicopathologic variables.

Design  A retrospective cohort study of 92 patients chosen randomly from patients treated between 1964 and 1993 with the diagnosis of laryngeal cancer. Prognostic factors including PCNA expression, grade, lymphovascular invasion, depth of tumor margins, neck metastasis, and clinical outcome were evaluated.

Setting  Hacettepe University Medical Faculty, Ankara, Turkey.

Patients  Eighty-five men and 7 women operated on for squamous cell carcinoma of the larynx were studied. Sixty-nine patients had total and 20 patients had partial laryngectomy with neck dissection, and 3 patients had endolaryngeal tumor excision.

Intervention  Hematoxylin and eosin–stained sections were reevaluated for grade, lymphovascular invasion, and depth of tumor margins; sections stained with monoclonal antibody against PC10 were examined for PCNA expression.

Results  The PCNA index correlated with grade, lymphovascular invasion, depth of tumor margins, neck metastasis, and local-regional recurrence. The PCNA index values of patients with occult metastasis were significantly higher than those of patients without metastasis (P=.006).

Conclusions  The PCNA index is a more sensitive variable than grade in predicting tumor proliferation, occult lymph node metastasis, and prognosis. These results suggest that the PCNA index can be used in decision making for treatment and assessment of prognosis in laryngeal carcinomas.


From the Departments of Otolaryngology, Head and Neck Surgery (Drs Saraç, Sefik Hosal, and Kaya), and Pathology (Dr Ayhan), Hacettepe University Faculty of Medicine, Ankara, Turkey.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer
Liu et al.
Mol. Pharmacol. 2005;68:635-643.
ABSTRACT | FULL TEXT  

Prognostic Significance of Jab1 Expression in Laryngeal Squamous Cell Carcinomas
Dong et al.
Clin. Cancer Res. 2005;11:259-266.
ABSTRACT | FULL TEXT  

Prognostic relevance of cell proliferation in head and neck tumors
Pich et al.
Ann Oncol 2004;15:1319-1329.
ABSTRACT | FULL TEXT  

Prognostic Value of CD44 Variant 6 in Laryngeal Epidermoid Carcinomas
Guler et al.
Arch Otolaryngol Head Neck Surg 2002;128:393-397.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.